For tissue repair and recovery, modalities such as Platelet-Rich Plasma (PRP) therapy and targeted nutritional support remain highly effective and fully compliant with FDA regulations
Emerging research suggests variants in GLP-1 receptor pathways, FTO genes, and MC4R signaling may influence individual response patterns and side-effect tolerance
Endogenous synthesis continues unchanged during and after supplementation, so stopping doesn't suppress your body's natural production
Incretins and obesity and metabolic syndrome A cross-sectional study including more than 4000 participants demonstrated that fasting GLP-1 and glucagon levels were higher in children and adolescents with overweight and obesity compared to a healthy population
This narrows arteries, raises blood pressure, and causes damage to organs like the liver, heart, and pancreas
The SURMOUNT-1 trial (tirzepatide, similar population) reported average weight loss up to about 20.9 percent at the highest dose over 72 weeks (Jastreboff AM, et al
